Cardiovascular Disease News and Research

Latest Cardiovascular Disease News and Research

National Kickoff Classic partners with Close the Gap campaign to raise heart disease risk factor awareness

Boston Scientific today announced that its Close the Gap campaign is partnering with the Kirk Herbstreit National Kickoff Classic to raise awareness of heart disease risk factors for women and minorities.

26 Aug 2010

Lotus Pharmaceuticals initiates R-Bambuterol Clinical Trial I on-schedule

Lotus Pharmaceuticals, Inc., a growing developer, manufacturer and seller of medicine and drugs in the People's Republic of China, announced today that it has entered R-Bambuterol Clinical Trial I on-schedule and is on-track to complete in six months. The studies will evaluate the safety and tolerability of the new drug as well as the biological activity by measuring responses in healthy volunteers.

26 Aug 2010

First World Congress on Ergothioneine to be held in Los Angeles, California in July 2011

OXIS INTERNATIONAL, INC. is proud to announce that it has initiated active planning for the First World Congress on Ergothioneine, to be held in Los Angeles, California in July 2011 (the specific date will be announced at a later date).

26 Aug 2010

Dose-defining Phase IIa trial of CXL-1020 initiated for treating patients with ADHF

Cardioxyl Pharmaceuticals, Inc., a clinical-stage pharmaceutical company developing therapeutic agents for the treatment of cardiovascular disease, today announced that it has initiated a dose-defining Phase IIa trial of its lead drug candidate, CXL-1020, for the treatment of patients with acute decompensated heart failure.

26 Aug 2010

23rd European College of Neuropsychopharmacology Congress to be held 28 Aug - 1 Sep 2010 in Amsterdam

Mental disorders, such as depression, anxiety disorders, addiction and schizophrenia are the core challenge of most health care systems around the world. In the EU alone, each year 27% of the total adult population - this corresponds to 83 Million citizens - suffer from mental disorders. Depression alone affects almost 20 million ranking in the EU as the most disabling disorder of all diseases.

26 Aug 2010

Study finds BPA exposure impacts endocrine changes in men

An international group of researchers led by the Peninsula Medical School and the University of Exeter have for the first time identified changes in sex hormones associated with BPA exposure in men, in a large population study. The study results are published in the latest issue of Environmental Health Perspectives.

26 Aug 2010

Berries can prevent age related brain degeneration: Study

According to a new study, berries like strawberries, blueberries and acai berries help to recycle toxic proteins that are linked to age-related memory loss and other mental decline.

25 Aug 2010

Celera granted US patent on LPA gene variant's association with increased risk for myocardial infarction

Celera Corporation today announced that the United States Patent and Trademark Office has issued United States Patent 7,781,168 relating to methods of determining heart attack risk by detecting the Ile4399Met genetic polymorphism in the protease-like domain of LPA.

25 Aug 2010

Statin therapy reduces cardiovascular disease risk in patients with high sensitivity C-reactive protein

People at intermediate risk of cardiovascular disease who have high levels of high sensitivity C-reactive protein (hsCRP), a blood marker for inflammation, could benefit from cholesterol-lowering therapy even if their cholesterol is already at desirable levels.

25 Aug 2010

Migraine with aura increases risk of heart disease: Research

Individuals who suffer from migraines with aura (temporary visual or sensory disturbances before or during a migraine headache) are at a higher risk of dying from heart disease or stroke.

25 Aug 2010

SureGene collaborates with Medco Health Solutions to conduct REST study

SureGene, LLC and the Medco Research Institute, LLC, a wholly-owned subsidiary of Medco Health Solutions, Inc., today announced that they have entered into a novel investigative research collaboration to evaluate whether variation in genetic biomarkers previously identified by SureGene can help predict drug response for widely prescribed antipsychotic drugs in patients with serious mental illness.

25 Aug 2010

Sleep deprivation and chronic disease

Sleep experts believe that sleep deprivation and inadequate sleep is becoming frightfully common and it can be bad for health in more ways than one. According to Harvard School of Medicine's Healthy Sleep site there is a real link between chronic diseases like diabetes, heart disease and depression and chronic lack of sleep.

24 Aug 2010

CVD prevention strategies for high-risk individuals may widen health inequalities

In a Policy Forum published this week in PLoS Medicine, Simon Capewell and Hilary Graham review different population strategies for preventing cardiovascular disease and conclude that screening and treating high-risk individuals may be ineffective and widen social inequalities. The authors conclude "there is evidence that CVD prevention strategies for screening and treating high-risk individuals may represent a relatively ineffective approach that typically widens social inequalities.

24 Aug 2010

Asian-Americans subgroups lack data on cardiovascular disease

Asians are the fastest-growing racial/ethnic group in the U.S., but data on cardiovascular disease is lacking. There are marked differences in heart disease risk and occurrence among Asian-American subgroups, but data on these subgroups is limited, prompting the American Heart Association to call for more research on this fastest-growing racial/ethnic group in the U.S., according to a scientific statement published in Circulation: Journal of the American Heart Association.

24 Aug 2010

'Pre-vascularization' of device prior to implantation sustains circulation and suppresses scar formation

By creating a unique system of blood vessels that is engineered to interact with the tissue surrounding an implanted device, the longevity and function of these devices may be better preserved, according to a study led by researchers in the University of Louisville/ Jewish Hospital's Cardiovascular Innovation Institute (CII).

24 Aug 2010

BTE, Leapfrog Group, and PROMETHEUS Payment support NBCH's eValue8 health plan evaluation program

As the U.S. moves forward with health reform, health care purchasers are working to eliminate waste, overuse, and misuse in the health care system at the point of care. To that end, several of the nation's foremost quality and measurement organizations – Bridges to Excellence (BTE), the Leapfrog Group, and PROMETHEUS Payment® – announced their support of eValue8™, a program of the National Business Coalition on Health (NBCH).

24 Aug 2010

Removing corticosteroid regimen after surgery results in better graft survival rates

University of Cincinnati (UC) analysis of 10 years of data from local kidney transplant patients shows that patients removed from a corticosteroid regimen shortly after surgery have better graft survival rates, better survival rates and fewer cardiovascular events than patients kept on the traditional regimen of long-term steroids.

24 Aug 2010

Study finds high glucose level blocks infectious bacteria detection, affects immunity

Research led by the Warwick Medical School at the University of Warwick has found that unhealthy glucose levels in patients with diabetes can cause significantly more problems for the body than just the well-known symptoms of the disease such as kidney damage and circulation problems.

24 Aug 2010

Genzyme announces publication of phase 2 clinical trial results of eliglustat tartrate for Gaucher disease

Genzyme Corporation announced today that the two-year follow-up results from the phase 2 clinical trial of its investigational therapy known as eliglustat tartrate have been accepted for publication in the journal Blood. The results have been pre-published on the journal's website and are available to subscribers.

23 Aug 2010

Researchers find medication for diabetes, smoking cessation

The script for two research teams inducted today into the American Chemical Society (ACS) scientific "hall of fame" the ACS Heroes of Chemistry is a tale of two pills. One team invented a medication that helps people with diabetes control their blood sugar levels. The second team invented a medicine that helps people stop smoking, an addiction that experts regard as today's single greatest preventable cause of death worldwide.

23 Aug 2010

Cardiovascular Disease News and Research

Latest Cardiovascular Disease News and Research

National Kickoff Classic partners with Close the Gap campaign to raise heart disease risk factor awareness

Lotus Pharmaceuticals initiates R-Bambuterol Clinical Trial I on-schedule

First World Congress on Ergothioneine to be held in Los Angeles, California in July 2011

Dose-defining Phase IIa trial of CXL-1020 initiated for treating patients with ADHF

23rd European College of Neuropsychopharmacology Congress to be held 28 Aug - 1 Sep 2010 in Amsterdam

Study finds BPA exposure impacts endocrine changes in men

Berries can prevent age related brain degeneration: Study

Celera granted US patent on LPA gene variant's association with increased risk for myocardial infarction

Statin therapy reduces cardiovascular disease risk in patients with high sensitivity C-reactive protein

Migraine with aura increases risk of heart disease: Research

SureGene collaborates with Medco Health Solutions to conduct REST study

Sleep deprivation and chronic disease

CVD prevention strategies for high-risk individuals may widen health inequalities

Asian-Americans subgroups lack data on cardiovascular disease

'Pre-vascularization' of device prior to implantation sustains circulation and suppresses scar formation

BTE, Leapfrog Group, and PROMETHEUS Payment support NBCH's eValue8 health plan evaluation program

Removing corticosteroid regimen after surgery results in better graft survival rates

Study finds high glucose level blocks infectious bacteria detection, affects immunity

Genzyme announces publication of phase 2 clinical trial results of eliglustat tartrate for Gaucher disease

Researchers find medication for diabetes, smoking cessation

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Cardiovascular Disease News and Research

Latest Cardiovascular Disease News and Research

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Newsletters you may be interested in